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Abstract--This paper will address two aspects regarding the antioxidative role of coenzyme Q 
(CoQ): (1) Is the antioxidant function of CoQ primary or secondary (coincidental), i.e. was this 
molecule selected during evolution to function primarily as an essential functional component 
of the mitochondrial electron transfer chain and oxidative phosphorylation processes, is its 
antioxidative capability merely a coincidence of its hydroquinone structure, or was its synthetic 
enzyme sequence selected on the basis of the advantage to the evolving organism of both 
functions of CoQ? (2) What is the mechanism whereby the hydroquinone (antioxidant) form 
of CoQ (CoQH2) is maintained in high proportion in the various and many membranes in 
which it resides, and in which an obvious electron transfer mechanism to reduce it is not 
present? The essentiality of the antioxidative role of CoQH 2 will be explored and compared to 
other primary and secondary antioxidants. Recent evidence implicating the two-electron quinone 
reductase, DT-diaphorase, in the maintenance of the reduced, antioxidant state of CoQ during 
the oxidative stress of exhaustive exercise will be presented, and a hypothesis concerning the 
evolutionary significance of DT-diaphorase will be offered. 
Introduction 
Evolving in the presence of oxygen must have presented a paradox to potentially aerobic 
organisms. On the one hand, oxygen was in abundant  supply and chemically well suited 
to act as the terminal electron acceptor for the major  energy transferring and conserving 
system, the mitochondrial  electron transfer chain. In addition, the end product  of these 
reactions, water,  was not toxic and was easily excreted. On the other  hand, molecular 
oxygen also had the capacity to accept an unpaired electron leading to the formation of 
damaging oxygen free radicals. In order to survive the evolutionary process of natural 
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selection and to establish themselves as species, it was necessary for aerobic organisms 
to develop and select successful means of preventing the formation of free radicals 
and/or mechanisms to convert them to nontoxic molecules (i.e. antioxidant defenses), 
and to repair free radical damage to the various cellular constituents. 
Discussion 
We synthesize a number of enzymes such as superoxide dismutases, catalases and 
peroxidases in order to convert oxidizing molecules, formed during metabolism, to 
innocuous chemical species. In addition, we obtain via nutritional means a number 
of antioxidants synthesized by other species for their own antioxidant protection, and 
utilize them as essential antioxidant defence devices. Among the latter category are 
vitamin E (a-tocopherol), 13-carotene (a form of vitamin A) and vitamin C (ascorbic 
acid). Although 13-carotene and ascorbic acid have important functions in addition to 
antioxidation, they, and especially vitamin E for which no other function is known 
(Tappel, 1965; Maguire et al. ,  1989), may be assigned to the category of "Primary or 
Essential Antioxidants". A number of other compounds whose primary functions may 
be unrelated to antioxidation but which, due to some aspect of their molecular structure 
and reactivity relating to their oxidation-reduction potential or reducing capacity, are 
able to perform as antioxidants, have been referred to as "Secondary or Incidental 
Antioxidants" (Beyer, 1990, 1992). A number of such molecules are formed, either 
as a result of anabolism or catabolism, whose primary functions, for which they were 
selected during evolution, are not related to their secondary, or incidental, antioxidative 
capacity. The extent and diversity of such secondary antioxidants in biological systems 
may be appreciated by perusing Table 1 which contains a list of such compounds. It 
should be acknowledged that many of the compounds listed in Table 1 have been shown 
to have met the criteria regarding "How to characterize a biological antioxidant" offered 
by Halliwell (1990). 
Table 1. A partial list of secondary or coincidental antioxidants functional in plant and animal 
systems* 
N-Acetylcysteine Dihydrolipoid acid Lactoferrin Proteolytic enzymes 
Anserine Diphenylamine Lipoate Protoporphyrin 
Apomorphine Ergothioneine M e l a n i n s  Pyrroloquinoline quinones 
Azelaic acid Estrogens Melatonin Pyruvate 
Bilirubin P-ethanolamine Monoamines Riboflavin 
Biliverdin Flavonoids Neopterin Spermine 
Ca 2+ channel blockers Glycated proteins Nitric oxide Tannic acid 
Caffeine Hemocyanin Orotic acid Taurine 
Carnitine Hemoglobin Ovothiol Thioctic acid 
Carnosine Histidine Phytic acid Thioproline 
Ceroloplasmin Homocarnosine Polyamines Urate 
Chlorophylls Hylauronic a c i d  Procyanidins Vanillin 
Cholesterol Hypotaurine Propinylcarnitine Xanthophylls 
*Due to space limitations, literature references to the table contents are not included. A 
complete list of references may be requested from the author. 
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The question has been presented: "Why are secondary metabolites (natural products) 
biosynthesized? (Williams et al . ,  1989). Several possibilities exist: (1) temporary 
mutation, (2) evolution in progress, (3) waste or detoxification products, (4) functional 
metabolic role and (5) repellent or attractant role. CoQ, which has received attention as 
an antioxidant in recent years, would appear to fit into category 4 as it was discovered 
as an essential member of the mitochondrial electron transfer chain by Crane et al. 
(1957) and as a functional component of the oxidative phosphorylation mechanism by 
Peter Mitchell in 1975. The antioxidative capacity of CoQ was first reported by Lea 
and Kwietney (1962) and the superior antioxidant capacity of the hydroquinone form of 
CoQ, equivalent to that of vitamin E, was reported in 1966 by Mellors and Tappel. This 
observation has been repeated many times in many laboratories since then, especially 
in Laura Landi's laboratory in Bologna (Landi et al. ,  1984, 1987, 1990a,b, 1991, 1992; 
Cabrini et al . ,  1991; Fiorentini et al. ,  1991, 1993; Merati et al. ,  1992; Solaini et al. ,  1987), 
Lars Ernster's laboratory in Stockholm (Ernster, 1984; Beyer et al . ,  1986, 1987; Glinn 
et al . ,  1992; Ernster et al. ,  1992; Ernster and Forsmark-Andrre, 1993), Lester Packer's 
(Lang et al. ,  1987; Kagan et al. ,  1990; Hiramatsu et al. ,  1991; Packer et al. ,  1991), Roland 
Stocker's (Stocker et al. ,  1991; Mohr et al. ,  1992; Suarna et al. ,  1993; Ingold et al . ,  1993), 
Jan Karlsson's (Karlsson, 1987; Karlsson et al. ,  1993) and my laboratory in Ann Arbor 
(Beyer, 1988). From these and other outstanding studies and other laboratories, the 
antioxidant properties of CoQH 2 would appear to be well established. This subject has 
been reviewed by this author on several occasions (Beyer, 1989a, 1990a,b, 1992; Beyer 
et al . ,  1986, 1987; Beyer and Ernster, 1990, Ernster and Beyer, 1991). Because of its 
primary role in such a vital and central function as mitochondrial electron transport and 
oxidative phosphroylation, it was assumed that its exclusive location was in the inner 
mitochondrial membrane and that its only function was in mitochondrial energy release 
and transformation. 
Beginning with the work of Sasty et al. (1961), Jayaraman and Ramasarma (1963), 
Crane and Morr6 (1977), and then the explosion of information from Gustav Dallner's 
laboratory in Stockholm (Kalrn et al. ,  1987; Elmberger et al. ,  1989; Appelqvist et al . ,  
1991; Thelin et al . ,  1992; Aberg et al. ,  1992; Swiezewaka et al . ,  1993), it became 
Table 2. Distribution of Coenzyme Q in subcellular fractions 
from rat liver. Values are means + S.E. of seven experiments 
(modified from Kal~n et al., 1987) 
Subcellular fraction Coenzyme Q9 
(p.g/mg protein) 
Homogenate 0.79 + 0.08 
Golgi vesicles 2.62 + 0.15 
Lysosomes 1.86 + 0.18 
Mitochondria 1.40 _+ 0.16 
Inner mitochondrial membrane 1.86 + 0.13 
Endoplasmic reticulum 0.15 + 0.02 
Peroxisomes 0.29 _+ 0.04 
Plasma membrane 0.74 + 0.07 
Cytosol 0.02 + 0.004 
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apparent that CoQ was distributed widely in various membranes of the cell. Table 2, 
from Dallner's laboratory, shows the wide distribution of CoQ and its concentrations in 
those compartments. It is notable that the concentration of CoQ is higher in the Golgi 
membranes, and as high in the lysosomal membrane, than in the inner mitochondrial 
membrane. The question of the function of CoQ in these diverse membranes was 
difficult to resolve until it was shown that, depending on the tissue, for the most 
part, well over 50% of the resident CoQ in a variety of rat and human tissues is in 
the reduced, antioxidant form (Aberg et al. ,  1992). 
Once it was known that CoQH 2 functions as an effective intramembrane antioxidant and 
that it is present in the reduced state in essentially all cellular membrane compartments, 
the question arose as to the mechanism whereby CoQ in these membranes is maintained 
largely in the hydroquinone state. As early as 1986, my colleagues Kerstin Nordenbrand, 
Lars Ernster and I stated: "It is conceivable that mitochondrial DT-diaphorase maintains 
CoQ in the hydroquinone state thereby promoting its antioxidant function" (Beyer et al. ,  
1986). DT-diaphorase, otherwise known as NAD(P)H:Quinone Acceptor Reductase 
and menadione reductase, is an inducible 2-electron quinone reductase which has been 
shown by Charles Huggins to prevent carcinogenesis from several quinone carcinogens 
capable of quinone cycling and consequent free radical production (Huggins and 
Fukunishi, 1964; Huggins et al. ,  1964, 1978; Huggins, 1979). About twenty years ago, 
Lars Ernster, a co-discoverer of DT-diaphorase, convinced Bruce Ames to demonstrate 
the antimutagenic properties of the liver S-9 fraction from rats in which this enzyme had 
been induced to high activity (Chesis et al. ,  1984). Juan Seguar-Aguilar, Lars Ernster 
and I also showed that the activity of DT-diaphorase is induced to high levels in rapidly 
proliferating cells such as HepG2 hepatoblastoma and the Zajdela ascites hepatoma, and 
labeled it an anticancer enzyme (Beyer et al. ,  1988). 
Although considerable information is known about the structure, prosthetic group, 
mechanism, gene and other aspects of DT-diaphorase (see e.g. Ernster et al. ,  1987), 
its normal function, i.e. the role for which it was selected during evolution, remains 
unresolved. In order to test the hypothesis that it may function to maintain membrane- 
bound CoQ in a reduced steady-state, we have assayed the extent of lipid peroxidation, 
the oxidation-reduction state of CoQ, and the DT-diaphorase activity of gastrocnemius 
muscles of control rats and rats injected with a potent inhibitor of DT-diaphorase, 
dicoumarol, and subjected them to severe oxidative stress by running them to 
exhaustion. All non-run control and dicoumarol-treated animals were killed and 
the gastrocnemius muscles removed and processed approximately 15 min following 
dicoumarol injection. The results of this experiment appear in Table 3. The extent of 
lipid peroxidation products, as thiobarbituric acid reacting substances (TBARS), were 
slightly higher in the dicoumarol-injected controls than in the non-treated controls (not 
significant). Running to exhaustion in a rodent treadmill increased TBARS about 3-fold 
in the non-dicoumarol injected rats and about 4-fold in the dicoumarol-injected, run-to- 
exhaustion group in which the DT-diaphorase activity was inhibited to approximately 
l/3 of the non-inhibited level. These data are consistent with a role for DT-diaphorase 
in the maintenance of the reduced, antioxidant form of CoQ. 
In order to test the DT-diaphorase-CoQ interaction further, we utilized an in situ 
technique, used previously in my laboratory (Starnes et al. ,  1987), which overcomes 
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Table 3. Effect of dicoumarol administration on lipid peroxidation, oxidation-reduction state of 
coenzyme Q and DT-diaphorase activity of gastrocnemius muscle of rats at rest and following 
oxidative stress induced by treadmill running to exhaustion 
Experimental Lipid Coenzyme Q*(%) DT-diaphorase 
condition peroxidation Oxidized Reduced activity 
Control 22.6 + 6.4 56 44 2.97 + 0.64 
Control + Dicoumarol 29.4 + 3.7 62 38 1.04 + 0.09 
Run to exhaustion 62.7 + 4.2 66 34 3.02 + 0.72 
Run to exhaustion + Dicoumarol 88.4 +_ 7.2 82 18 0.92 + 0.10 
Lipid peroxidation as ixmols MDA/g tissue wet weight. Dicoumarol administered i.p. at 
3 mg/100 g body weight 15 min prior to exercise commencement. Control animals + dicoumarol 
were killed following a treatment period equivalent to time required for run to exhaustion. 
Oxidized and reduced states of CoQ were determined according to a modification of the 
method of Beyer (1989b). DT-diaphorase as nmols cytochrome c reduced/min/mg protein. 
Values reported as mean + S.E.M. Each group consisted of eight animals. 
*The concentration of total coenzyme Q in terms of pmoles/mg protein (224.6 + 18.4) did not 
differ statistically between groups. 
some of the disadvantages of both in vivo and in vitro techniques. Briefly, adult 
male Sprague-Dawley rats (c. 450 g) were anesthetized with Na-Pentobarbital,  and 
the gastrocnemius-plantarus-soleus muscles of the left leg were exposed. The tendons 
were severed at the ankle, the knee joint stabilized, and the muscles were stretched 
15-20% beyond resting length by attaching a weight of 100 g. For muscles which were to 
receive electrical stimulation, needle electrodes were inserted directly into the muscles 
and stimulated with two supramaximal pulses/sec for 90 min. The isotonic contractions 
were monitored to assure maximal contractions and the muscles were bathed with 
Ringer's solution at 37°C. Control values represent the contralateral limb which was 
treated similarly, but not stimulated. As in the previous experiment,  dicoumarol was 
administered about 15 min prior to initiation of electrical stimulation. 
The results of the in situ stimulation experiments (Table 4) also demonstrate that 
inhibition of quinone reductase activity results in an increase in free radical damage, 
measured as TBARS via lipid peroxidation. Although such data are somewhat indirect 
and other explanations are plausible, they are consistent with a CoO reductase 
function for DT-diaphorase under physiological conditions, and support the concept 
of an important function for DT-diaphorase in maintaining a significant level of the 
hydroquinone form of CoQ in the various membranes of the cell, thus allowing 
this hydroquinone to act as an effective antioxidant in such hydrophobic cellular 
compartments.  Although the majority of DT-diaphorase activity resides in the cytosolic 
compartment,  its assay in vitro requires the presence of non-ionic detergent for maximal 
activity. This suggests that the cytosolic DT-diaphorase may interact with membrane 
components located near the membrane-cytosol  interface similar to the interaction 
of cytosolic ascorbate and membrane-bound oL-tocopheroxyl radical to regenerate 
a-tocopherol ,  the reduced, antioxidant state of vitamin E (Beyer,  1994). The long 
(45 carbons in rats, 50 in humans) polyisoprenoid side chain of CoO may allow 
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Table 4. Effect of dicoumarol administration on lipid peroxidation, coenzyme Q oxidation- 
reduction state and cytosolic DT-diaphorase activity of in situ electrically stimulated 
gastrocnemius muscle of rats 
Treatment Lipid peroxidation CoQ (% reduced) DT-diaphorase 
Control* 27.7 _+ 7.4 51 3.01 + 0.41 
Stimulated control 36.2 _+ 5.4 36 2.87 + 0.62 
Dicoumarol* 44.4 _+ 6.2 33 0.92 _+ 0.21 
Dicoumarol stimulated 96.4 __+ 8.7 14 0.77 + 0.17 
In situ stimulation method as reported previously (Starnes et al., 1987). Lipid peroxidation as 
~mois MDA/g tissue. 3 mg dicoumarol/100 g body weight administered 15 min prior to start of 
electrical stimulation. 
*Control and dicoumarol-treated were the right contralateral gastrocnemius of left-limb- 
stimulated rats. Reduced state of CoQ was determined using a modification of Beyer (1989b). 
Cytosolic DT-diaphorase as nmols cytochrome c reduced/min/mg protein (Beyer et al., 1988). 
Values as mean _+ S.E.M.; n=8. 
the quinone moiety of CoQ to move to the membrane surfaces (Siedo and Stidman, 
1986; Lenaz et al.,  1992; Samori et al., 1992; Fato et al., 1986; Ondarroa and Quinn, 
1986; Cornell et al.,  1987) in order to interact with, and receive reducing equivalents 
from DT-diaphorase. Very recent evidence (Salgado et al.,  1993) utilizing the magic 
angle spinning 13C-NMR spin-lattice relaxation technique indicates that CoQH 2 can 
flip-flop across membranes, carrying reducing equivalents for energy conservation 
and/or antioxidation purposes. In addition, the report of three distinct CoQ pools 
in heart mitochondria (JOrgensen et al.,  1985) may be consistent with the notion of 
multiple function for CoQ. 
Additional evidence supporting the concept of chemical interaction between DT- 
diaphorase and long polyisoprenoid side chain CoQ has appeared in recent reports 
of CoQ-binding proteins with DT-diaphorase activity in liver soluble fractions which 
may function to transport CoQ from its site of synthesis in the endoplasmic reticulum to 
various other sites (Kishi et al.,  1991), and the characterization of dicoumarol-sensitive 
NAD(P)H-dependent CoQ reductase activities in rat liver microsomes (Shigsemura 
et al.,  1993). It is also of interest that CoQH 2 has been reported to be a more efficient 
antioxidant with respect to lipid peroxidation of human low density lipoprotein when 
compared to e~-tocopherol (Stocker et al.,  1991; Ingold et al.,  1993). 
Conclusion 
The question of whether CoQ should be considered an essential (primary) or a 
secondary (coincidental) antioxidant must be addressed. The voluminous litrature 
supporting its antioxidant role, in addition to beneficial effects of CoQ therapy, 
lacking detectable toxic side effects (Langsjoen et al.,  1991), effective in a large 
number of clinical pathologies reported in previous symposia on CoQ (Folkers and 
Yamamura, 1977, 1981, 1984, 1986; Folkers et al.,  1991; Lenaz, 1985; Lenaz et al.,  
1990; Conference on Coenzyme Q, 1993; Yamamura et al., 1980), would now appear 
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to support the concept of a primary, essential function for CoQ in acting as a 
chain-breaking antioxidant in the various membranes of the cell, in addition to its 
role in regenerating the active form of vitamin E. 
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